These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Spontaneous pain-associated facial expression and efficacy of clinically used drugs in the reserpine-induced rat model of fibromyalgia. Nagakura Y; Miwa M; Yoshida M; Miura R; Tanei S; Tsuji M; Takeda H Eur J Pharmacol; 2019 Dec; 864():172716. PubMed ID: 31589868 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of the analgesic effects of ammoxetine, a novel potent serotonin and norepinephrine reuptake inhibitor. Zhang TT; Xue R; Zhu L; Li J; Fan QY; Zhong BH; Li YF; Ye CY; Zhang YZ Acta Pharmacol Sin; 2016 Sep; 37(9):1154-65. PubMed ID: 27424654 [TBL] [Abstract][Full Text] [Related]
25. Isobolographic Analysis of Drug Combinations With Intrathecal BRL52537 (κ-Opioid Agonist), Pregabalin (Calcium Channel Modulator), AF 353 (P2X3 Receptor Antagonist), and A804598 (P2X7 Receptor Antagonist) in Neuropathic Rats. Jung YH; Kim YO; Han JH; Kim YC; Yoon MH Anesth Analg; 2017 Aug; 125(2):670-677. PubMed ID: 28277328 [TBL] [Abstract][Full Text] [Related]
26. Oral Supplementation of Melatonin Protects against Fibromyalgia-Related Skeletal Muscle Alterations in Reserpine-Induced Myalgia Rats. Favero G; Trapletti V; Bonomini F; Stacchiotti A; Lavazza A; Rodella LF; Rezzani R Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28661421 [TBL] [Abstract][Full Text] [Related]
27. Pregabalin reduces muscle and cutaneous hyperalgesia in two models of chronic muscle pain in rats. Yokoyama T; Maeda Y; Audette KM; Sluka KA J Pain; 2007 May; 8(5):422-9. PubMed ID: 17293165 [TBL] [Abstract][Full Text] [Related]
28. Peripheral and spinal mechanisms of nociception in a rat reserpine-induced pain model. Taguchi T; Katanosaka K; Yasui M; Hayashi K; Yamashita M; Wakatsuki K; Kiyama H; Yamanaka A; Mizumura K Pain; 2015 Mar; 156(3):415-427. PubMed ID: 25599239 [TBL] [Abstract][Full Text] [Related]
29. Involvement of TRPV1 and the efficacy of α-spinasterol on experimental fibromyalgia symptoms in mice. Fischer SPM; Brusco I; Brum ES; Fialho MFP; Camponogara C; Scussel R; Machado-de-Ávila RA; Trevisan G; Oliveira SM Neurochem Int; 2020 Mar; 134():104673. PubMed ID: 31926196 [TBL] [Abstract][Full Text] [Related]
30. Stereospecific effect of pregabalin on ectopic afferent discharges and neuropathic pain induced by sciatic nerve ligation in rats. Chen SR; Xu Z; Pan HL Anesthesiology; 2001 Dec; 95(6):1473-9. PubMed ID: 11748408 [TBL] [Abstract][Full Text] [Related]
31. Nano-pregabalin effectively mitigates Glut, CGRP and NE neurotransmitters abnormalities in the brain of gamma irradiated rats with reserpine-induced fibromyalgia model: Behavioral and neurochemical studies. Samy EM; Radwan RR; Mosallam FM; Mohamed HA Neuropharmacology; 2024 Dec; 261():110162. PubMed ID: 39299572 [TBL] [Abstract][Full Text] [Related]
32. Acid-induced hyperalgesia and anxio-depressive comorbidity in rats. Liu YT; Shao YW; Yen CT; Shaw FZ Physiol Behav; 2014 May; 131():105-10. PubMed ID: 24726391 [TBL] [Abstract][Full Text] [Related]
33. A model of neuropathic pain induced by sorafenib in the rat: Effect of dimiracetam. Di Cesare Mannelli L; Maresca M; Farina C; Scherz MW; Ghelardini C Neurotoxicology; 2015 Sep; 50():101-7. PubMed ID: 26254739 [TBL] [Abstract][Full Text] [Related]
34. Comparative analgesic efficacy of pregabalin administered according to either a prevention protocol or an intervention protocol in rats with cisplatin-induced peripheral neuropathy. Han FY; Kuo A; Nicholson JR; Corradinni L; Smith MT Clin Exp Pharmacol Physiol; 2018 Oct; 45(10):1067-1075. PubMed ID: 29781509 [TBL] [Abstract][Full Text] [Related]
35. [The effect of berberine on ameliorating chronic inflammatory pain and depression]. Xu F; Yang J; Meng B; Zheng JW; Liao Q; Chen JP; Chen XW Zhonghua Yi Xue Za Zhi; 2018 Apr; 98(14):1103-1108. PubMed ID: 29690724 [No Abstract] [Full Text] [Related]
36. Pharmacological characterisation of a rat model of incisional pain. Whiteside GT; Harrison J; Boulet J; Mark L; Pearson M; Gottshall S; Walker K Br J Pharmacol; 2004 Jan; 141(1):85-91. PubMed ID: 14597606 [TBL] [Abstract][Full Text] [Related]
37. Relationships among pain and depressive and anxiety symptoms in clinical trials of pregabalin in fibromyalgia. Arnold LM; Leon T; Whalen E; Barrett J Psychosomatics; 2010; 51(6):489-97. PubMed ID: 21051680 [TBL] [Abstract][Full Text] [Related]
38. Therapeutic Approaches to Nociplastic Pain Based on Findings in the Reserpine-Induced Fibromyalgia-Like Animal Model. Nagakura Y J Pharmacol Exp Ther; 2022 May; 381(2):106-119. PubMed ID: 35246482 [TBL] [Abstract][Full Text] [Related]
39. Pregabalin: its efficacy, safety and tolerability profile in fibromyalgia syndrome. Owen RT Drugs Today (Barc); 2007 Dec; 43(12):857-63. PubMed ID: 18174971 [TBL] [Abstract][Full Text] [Related]
40. Time-shifted co-administration of sub-analgesic doses of ambroxol and pregabalin attenuates oxaliplatin-induced cold allodynia in mice. Furgała A; Fijałkowski Ł; Nowaczyk A; Sałat R; Sałat K Biomed Pharmacother; 2018 Oct; 106():930-940. PubMed ID: 30119265 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]